Sturnira hondurensis: 118993073
Help
Entry
118993073 CDS
T07222
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
shon
Sturnira hondurensis
Pathway
shon01524
Platinum drug resistance
shon04010
MAPK signaling pathway
shon04115
p53 signaling pathway
shon04148
Efferocytosis
shon04210
Apoptosis
shon04215
Apoptosis - multiple species
shon04623
Cytosolic DNA-sensing pathway
shon04650
Natural killer cell mediated cytotoxicity
shon04657
IL-17 signaling pathway
shon04668
TNF signaling pathway
shon04726
Serotonergic synapse
shon04932
Non-alcoholic fatty liver disease
shon04933
AGE-RAGE signaling pathway in diabetic complications
shon04936
Alcoholic liver disease
shon05010
Alzheimer disease
shon05012
Parkinson disease
shon05014
Amyotrophic lateral sclerosis
shon05016
Huntington disease
shon05020
Prion disease
shon05022
Pathways of neurodegeneration - multiple diseases
shon05132
Salmonella infection
shon05133
Pertussis
shon05134
Legionellosis
shon05145
Toxoplasmosis
shon05146
Amoebiasis
shon05152
Tuberculosis
shon05160
Hepatitis C
shon05161
Hepatitis B
shon05162
Measles
shon05163
Human cytomegalovirus infection
shon05164
Influenza A
shon05165
Human papillomavirus infection
shon05167
Kaposi sarcoma-associated herpesvirus infection
shon05168
Herpes simplex virus 1 infection
shon05169
Epstein-Barr virus infection
shon05170
Human immunodeficiency virus 1 infection
shon05200
Pathways in cancer
shon05203
Viral carcinogenesis
shon05205
Proteoglycans in cancer
shon05206
MicroRNAs in cancer
shon05210
Colorectal cancer
shon05222
Small cell lung cancer
shon05416
Viral myocarditis
shon05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
shon00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
118993073 (CASP3)
04668 TNF signaling pathway
118993073 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
118993073 (CASP3)
09143 Cell growth and death
04210 Apoptosis
118993073 (CASP3)
04215 Apoptosis - multiple species
118993073 (CASP3)
04115 p53 signaling pathway
118993073 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
118993073 (CASP3)
04650 Natural killer cell mediated cytotoxicity
118993073 (CASP3)
04657 IL-17 signaling pathway
118993073 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
118993073 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
118993073 (CASP3)
05206 MicroRNAs in cancer
118993073 (CASP3)
05205 Proteoglycans in cancer
118993073 (CASP3)
05203 Viral carcinogenesis
118993073 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
118993073 (CASP3)
05222 Small cell lung cancer
118993073 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
118993073 (CASP3)
05161 Hepatitis B
118993073 (CASP3)
05160 Hepatitis C
118993073 (CASP3)
05164 Influenza A
118993073 (CASP3)
05162 Measles
118993073 (CASP3)
05168 Herpes simplex virus 1 infection
118993073 (CASP3)
05163 Human cytomegalovirus infection
118993073 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
118993073 (CASP3)
05169 Epstein-Barr virus infection
118993073 (CASP3)
05165 Human papillomavirus infection
118993073 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
118993073 (CASP3)
05133 Pertussis
118993073 (CASP3)
05134 Legionellosis
118993073 (CASP3)
05152 Tuberculosis
118993073 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
118993073 (CASP3)
05145 Toxoplasmosis
118993073 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
118993073 (CASP3)
05012 Parkinson disease
118993073 (CASP3)
05014 Amyotrophic lateral sclerosis
118993073 (CASP3)
05016 Huntington disease
118993073 (CASP3)
05020 Prion disease
118993073 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
118993073 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
118993073 (CASP3)
05416 Viral myocarditis
118993073 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
118993073 (CASP3)
04932 Non-alcoholic fatty liver disease
118993073 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
118993073 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
118993073 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
shon01002
]
118993073 (CASP3)
Enzymes [BR:
shon01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
118993073 (CASP3)
Peptidases and inhibitors [BR:
shon01002
]
Cysteine peptidases
Family C14: caspase family
118993073 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
118993073
NCBI-ProteinID:
XP_036911052
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTENSVDSKSIKNSETRLIHGSKSVDSGIPLDCSYKMDYPEMGVCLIINNKNFHKNTG
MTCRSGTDVDAANLRETFMNLKYEVRNKNDLTCEEMVELMRSVSEEDHGKRSSFVCVLLS
HGEEGVIFGTNGAVELRDLTRFFRGDCCRSLTGKPKLFIVQACRGTELDCGIETDSGVDD
DVTCQKIPVEADFLYAYSTAPGYYSWRNAKDGSWFIQALCAMLKQYADKLELMHILTRVN
RKVAIEFESFSFDPNFHAKKQIPCIVSMLTRELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacacggaaaactcagtggattcaaaatccattaaaaactcagaaacgaggctc
atacatggcagtaaatcagtggactctgggatacccttggactgtagttacaaaatggac
taccccgaaatgggcgtctgcttaataatcaataataaaaactttcataaaaatactgga
atgacatgtcggtctggcacagatgtagacgcagcaaacctcagggagacgttcatgaac
ttgaaatacgaagtcaggaacaaaaacgatcttacatgcgaagaaatggtggaattgatg
cgcagcgtttctgaagaagaccatggcaagaggagcagtttcgtctgcgtgcttctgagc
cacggggaggaaggcgtcatttttggaacaaacggagccgttgagctgcgagacttaacg
cgtttcttccgcggggattgctgcaggagtctgaccggaaagcccaagcttttcattgtt
caggcctgccgaggcacagagctggactgcggcatcgagaccgacagcggcgttgacgat
gacgtgacgtgtcagaaaattcccgtggaggcagacttcctgtatgcgtattctacagcg
cctggttactattcctggagaaatgccaaggacgggtcctggttcatccaggcactctgt
gctatgctgaaacagtacgcggacaagctggagctcatgcacattctgactcgggttaac
cggaaggtagcgatagaatttgagtccttttccttcgaccctaactttcatgcaaagaaa
cagattccatgcattgtttctatgctcacaagagagctgtatttttatcactaa
DBGET
integrated database retrieval system